BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
10 hedge funds and large institutions have $73.2K invested in Baudax Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
-10
Holders Change %
-50%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$59.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.43K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$455 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$7 |
